Georgia CTSA Newsletter
|
Trouble viewing this email? View on the web.
| |
| |
Georgia CTSA Weekly eRoundup
March 27, 2020
|
| |
| | | | Christina Fournier, MD, Co-Director of the Emory Amyotrophic Lateral Sclerosis (ALS) Center and Georgia Clinical & Translational Science Alliance (Georgia CTSA) Master in Science in Clinical Research (MSCR) graduate, worked to create a highly innovative telemedicine system for Emory ALS Center patients in partnership with Dr. Jonathan Glass and the Emory ALS Center team. These patients can now receive their care from home and avoid going to the clinic, ... | | Read More | |
|
| |
| | | | Join this special Georgia CTSA webinar on March 31 from 9:00-10:00am. Hear from the experts and share your experiences! Robin Ginn (Assistant VP, Research Administration and Executive Director, Office of Clinical Research), Rebecca Rousselle (Director, Emory IRB) and others will lead an online discussion around the ramp down of clinical trials. | | Register | |
|
| |
| | Thank you to our outstanding partners at Georgia Tech who designed and manufactured in-house 5,000 face shields and delivered them to Emory Healthcare yesterday to protect our front line workers in the fight against COVID-19! The Georgia Tech team is collaborating with Georgia Pacific, Siemens and other companies to scale these creations to mass production. | | Learn More | |
| |
| | Are you an Emory SOM researcher working on research relating to COVID-19? If so, please reach out to Gayathri Srinivasan Ph.D., gayathris@emory.edu, and send a brief summary of your COVID-19 related project. Should there be any appropriate partnering or funding opportunities, Gayathri will share them with you. This is not a funding mechanism and there are no guarantees on funding. This is for informational purposes while we engage with corporate partners to find opportunities to address this pandemic. | | Contact | |
| |
| | We wanted you to be aware of the release of the “Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need” that the NCATS CTSA Program just released. See link below. | | Read More | |
| |
| | NCATS has not received additional funding for COVID-19 activities, but other opportunities are posted on the NIH website for COVID-19 using other funding. | | Read More | |
| |
| | Mike Lauer, the Deputy Director for Extramural Research at NIH (host of NIH's popular "Open Mike" NIH research blog) has put together a short (8:38) video that addresses the most frequently asked questions that NIH program officers are receiving these days about (submitting, implementing, altering, and reporting) NIH research during COVID-19, https://www.youtube.com/watch?v=jLmBi5wvifk&feature=youtu.be. | | Read More | |
| |
| | For details on expanded flexibilities, such as mid-project period extensions and administrative supplements for unanticipated costs, see NOT-OD-20-087. | | Read More | |
| |
| | When delays occur because the applicant or recipient organization is officially closed or unable to submit grant applications due to the effects of COVID-19, the NIH will consider accepting applications late, on a case-by-case basis. See the Guidance Notes. | | Read More | |
| |
| | For flexibilities provided in the Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals (Policy) that are applicable to implementing a pandemic plan for animal care and use programs, see NOT-OD-20-088. | | Read More | |
| |
| | Georgia CTSA's Informatics program is soliciting proposals to support investigator-led teams in developing and testing innovative healthcare apps. The support is for project costs that are associated with data access, informatics resource access, and technical personnel. We strongly encourage applications that use our Real Time Analytics platform. Applications that do not include budget lines for informatics resources will be considered non-responsive. | | Read More | |
| |
| | Pfizer Global Medical Grants (GMG) supports the global healthcare community's independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer's medical and/or scientific strategies. Projects that will be considered for Pfizer support will focus on increasing the understanding of targeted therapies including BRAF inhibitors and their use in the treatment of colorectal cancer (CRC). | | Read More | |
| |
| | This RFP is intended to support quality improvement (QI) initiatives that focus on the implementation of updated pneumococcal immunization recommendations, as described in the updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for adult pneumococcal immunization. | | Read More | |
| |
| | The funding priority for the seed grants from the Emory-Georgia Tech Healthcare Innovation Program will be for proposals that address issues in dealing with pandemics such as (but not limited to): coordination of public health and healthcare systems in clinical responses, diagnostic testing, provider-patient safety; improving clinical preparedness and communication; impact on healthcare system physicians, nurses, staff. | | Read More | |
| |
| | In light of the current COVID-19 outbreak, the dean of the Emory School of Medicine (SOM) has created a special grant cycle of the Dean’s Imagine, Innovate, and Impact (I3) Awards. This I3 Rapid RFP will specifically support the creation of data in preparation for anticipated external funding opportunities related to COVID-19. | | Read More | |
| |
| | Pfizer Global Medical Grants (GMG) supports the global healthcare community's independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer's medical and/or scientific strategies. Projects that will be considered for Pfizer support will focus on increasing the understanding of MAPK pathway inhibitors and their use in the treatment of melanoma. | | Read More | |
| |
| | (NOTE: Funding rules have been updated.) To assist investigators who have temporarily lost significant federal research funding, and to facilitate carefully planned changes in research direction, the Emory School of Medicine offers a Bridge Funding Program. Bridge funding up to $100,000 (including Department support/matching funds) will be available to investigators based on merit, potential for renewal of external funding, and availability of SOM funds. | | Read More | |
| |
| | Through this RFP, it is our intent to support virtual programs for dermatologists & allergists on new emerging therapies for moderate-to-severe atopic dermatitis. Programs targeted towards reviewing data from canceled dermatology or allergy medical conferences are of particular interest. | | Read More | |
| |
| | Wake Forest Primate Signature Program provides access to nonhuman primates (NHPs) and related resources for studies that advance translational research. To assist new NHP researchers, the Program is providing funds for feasibility studies to be conducted using monkey-related resources. The objective is to facilitate the collection of data from NHPs in support of applications for extramural funding. Applications are open to faculty members or KL2 scholars of CTSA supported institutions. | | Read More | |
| |
| | A key innovation strategy is to promote interdisciplinary and cross-departmental and -divisional research. The SOM I3 Education Awards are soliciting proposals that highlight, promote, and disseminate innovations in medical education and training (degree programs and GME) that enhance the Emory SOM mission. Please note that the project start date is now listed as “TBD.” We will re-evaluate the start date when we review proposals and better understand where research stands across Emory at that time. | | Read More | |
| |
| | AMAG Pharmaceuticals, Inc. is committed to funding research aimed at reducing the risk of premature birth and preeclampsia in order to improve the health of neonates and infants in the United States through its 2020 Prematurity and Preeclampsia Research Grants Program for a total of $250,000. Consideration will be given to basic or clinical research in maternal, fetal and neonatal/infant health. | | Read More | |
| |
| | The purpose of this Notice of Special Interest is to highlight the list of widely appreciated systematic barriers or translational science problems included in PAR-19-099 and PAR-19-100 to add the following topics of interest: Rural Health, Racial and Ethnic Disparities in Maternal Mortality, Applications for Machine Learning and Artificial Intelligence (AI), Veterans' Health. | | Read More | |
| |
| | The Emory Master of Science in Clinical Research (MSCR) degree program, in the Laney Graduate School at Emory University, provides innovative didactic and mentored research training to those interested in pursuing a career in clinical and/or translational research. | | Read More | |
| |
| | The Certificate Program in Translational Research (CPTR) is a formal 16-credit Emory Laney Graduate School program for trainees who seek to conduct research at the interface between basic and translational science and clinical medicine. | | Read More | |
| |
| | The Medical Innovation Residency Track is a 24-month program now open to both Emory and MSM participants to provide a foundation of knowledge to participate in entrepreneurship and design for innovate technologies. Upon successful participation and completion of this track, residents will be awarded a certificate of distinction in Medical Innovation from Emory University School of Medicine. | | Read More | |
| |
| | Phlebotomy 101 is a two-day classroom and clinical, hands-on training to venipuncture offered through the Georgia CTSA Clinical Research Centers (GCRCs). The course is offered quarterly to research coordinators from Emory, Morehouse School of Medicine and UGA. | | Class Schedule | |
| |
| | The new Georgia CTSA Grant Wise service offers the opportunity for one-on-one feedback from experienced senior faculty on grant writing. We are soliciting experienced faculty to serve as volunteer mentors. If you have experience in writing grants and you enjoy mentoring, we need you! After completing the online volunteer form, we will be in touch should we receive a request that matches your expertise. Contact lauren.james@emory.edu | | Volunteer Form | |
| |
| | Georgia CTSA is now offering Virtual Studios to meet your research brainstorming needs. Our on-site presence has temporarily changed, but our desire to help you plan and collaborate regarding existing and potential research has not paused. Examples of areas where we have served past customers with expert brainstorming include locating collaborators and resources, hypothesis generation, study design, implementation, analysis and interpretation, translation and manuscript development of research topics. A recent research team who completed a Virtual Studio consults said, “The brainstorming enabled us to meet and share ideas and resources remotely, connect with key experts and keep our PI's and research team’s planning and momentum flowing toward the future. The Virtual STUDIO allows everyone at any location to join the meeting (including those who are remote working and also those who can’t leave OR/clinic), and it saves time from travelling to the meeting location too!” Contact the Georgia CTSA Coordinating Center by emailing Karen Lindsley at klindsl@emory.edu or Submit a Request for a Studio Consultation. | | Submit a Request | |
| |
| | Do you have essential mouse lines that are critical to your research program? If so, you should be aware that the Mouse Transgenic and Gene Targeting Core (TMF) and the Division of Animal Resources (DAR) teams are working together to help Emory researchers protect their research in the context of COVID-19. Cryopreserving your essential mouse lines is one of the best ways to protect your research! | | Read More | |
| |
| | In an effort to meet the varied needs of our stakeholders, we provide three different versions of our message on COVID-19 Core Facilities Operations Update. | | Read More | |
| |
| | In an effort to meet the varied needs of our stakeholders, Emory provides three different versions of our message on Animal Preservation Measure 1. Please direct any questions to Dr. Michael Huerkamp: 7-3248; mhuerka@emory.edu. | | Read More | |
| |
| | In an effort to meet the varied needs of our stakeholders, we provide three different versions of our message on COVID-19 and Personal Protective Equipment. Please direct any questions to Dr. Michael Huerkamp: 7-3248; mhuerka@emory.edu. | | Read More | |
| |
| | In an effort to meet the varied needs of our stakeholders, we provide three different versions of our message on COVID-19 and DAR Phase 2 Operations (3/25/2020). | | Read More | |
| |
| | Protocol Deviation: Two Protocol Deviations (PDF) | | Read More | |
| |
| | Registration is now open for the SBIR Road Tour stopping at UGA in Athens, GA. National outreach effort connecting entrepreneurs working on advanced technologies to the country’s largest source of early stage funding – the SBIR/STTR programs. Opportunity for small businesses, innovators, researchers, entrepreneurs and technology companies to connect directly with SBIR/STTR program managers representing more than a dozen different federal agencies. SBIR/STTR programs provide over $3.7 billion in funding to small businesses each year in a wide variety of technology areas. | | Read More & Register | |
| |
| | | The Georgia CTSA recently partnered with the All of Us Research Program. All of Us is a health research program funded by the National Institutes of Health (NIH). Its goal is to help researchers better understand why people get sick or stay healthy. The mission of the All of Us Research Program is simple: to speed up health research and medical breakthroughs. To do this, All of Us is asking one million people from across the U.S. to share their health ... | | Read More | |
| |
| | Hear from the experts and share your experiences! Robin Ginn (Assistant VP, Research Administration and Executive Director, Office of Clinical Research), Rebecca Rousselle (Director, Emory IRB) and others will lead an online discussion around the ramp down of clinical trials on March 31st from 9:00 am – 10:00 am. | | Register | |
| |
| | Learn the pros and cons of different commercialization strategies to help determine the best fit for your technology. Our panel discussion format will allow you to ask questions and receive feedback to better understand complex go-to-market strategies. Registration link coming soon. Please note all talks for the remainder of this series will be hosted via webinar. | | Read More | |
| |
| | Please join our Georgia CTSA Clinical Research Centers (GCRCs) staff for a very special 60th Anniversary Open House showcase on May 1st at the Emory University Hospital location, Unit HG-02. Tour and info sessions at 10:00am, 12:30pm, and 2:00pm. | | Read More | |
| |
| | 2020 Statistical Methods in Imaging (SMI) Conference will be held at Emory Rollins School of Public Health (RSPH). The SMI conference is the annual meeting of the ASA Statistics in Imaging section. Please be aware that due to global concern over coronavirus, the dates of the conference are subject to change. | | Read More | |
| |
| | Georgia CTSA is proud to announce it is a Silver Sponsor of this year's conference at the Georgia Aquarium! Registration is open now. Georgia CTSA Innovation Catalyst Director Wilbur Lam, MD, PhD, is this year's co-chair. CME is also offered. | | Read More | |
| |
| | Come join us for this annual symposium event showcasing local basic and clinical research conducted by our fellows and junior faculty conducting pediatric research on Tuesday, August 4 at the Health Sciences Research Building Auditorium and Café. | | Read More | |
| |
| For more information on Georgia Clinical & Translational Science Alliance (Georgia CTSA), please visit
www.GeorgiaCTSA.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
GeorgiaCTSA@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
GeorgiaCTSA@emory.edu.
Please include the following citation in any publications resulting from direct or indirect Georgia CTSA support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2TR002381 and TL1 Trainees should also list TL1TR002382. |
| |
|